Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/18086
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBROUX, Bieke-
dc.contributor.authorShamim, Z.-
dc.contributor.authorWang, T.-
dc.contributor.authorSpellman, S.-
dc.contributor.authorHaagenson, M.-
dc.contributor.authorSTINISSEN, Piet-
dc.contributor.authorRyder, L. P.-
dc.contributor.authorMuller, K.-
dc.contributor.authorHELLINGS, Niels-
dc.date.accessioned2015-01-12T13:45:42Z-
dc.date.available2015-01-12T13:45:42Z-
dc.date.issued2014-
dc.identifier.citationINTERNATIONAL JOURNAL OF IMMUNOGENETICS, 41 (6), p. 521-527-
dc.identifier.issn1744-3121-
dc.identifier.urihttp://hdl.handle.net/1942/18086-
dc.description.abstractWe investigated the influence of IL-7 receptor -chain (IL-7R) gene haplotypes in donors on the outcome of haematopoietic cell transplantation (HCT). Unlike the association between single donor SNPs and HCT outcome found previously, only trends towards association were found here, due to dilution' of SNPs into haplotypes.-
dc.description.sponsorshipThis project was funded by Hasselt University, Fonds voor Wetenschappelijk Onderzoek, Belgian Charcot Foundation, University Hospital Rigshospitalet Copenhagen, the Dagmar Marshall Foundation and the Danish Cancer Society. The CIBMTR is supported by Public Health Service Grant/Cooperative Agreement U24-CA076518 from the National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID); a Grant/Cooperative Agreement 5U10HL069294 from NHLBI and NCI; a contract HHSH250201200016C with Health Resources and Services Administration (HRSA/DHHS); two Grants N00014-14-1-0028 and N00014-13-1-0039 from the Office of Naval Research; and grants from Actinium Pharmaceuticals; Allos Therapeutics, Inc.; Amgen, Inc.; Anonymous donation to the Medical College of Wisconsin; Ariad; Be the Match Foundation; Blue Cross and Blue Shield Association; Celgene Corporation; Chimerix, Inc.; Fred Hutchinson Cancer Research Center; Fresenius-Biotech North America, Inc.; Gamida Cell Teva Joint Venture Ltd.; Genentech, Inc; Gentium SpA; Genzyme Corporation; GlaxoSmithKline; Health Research, Inc. Roswell Park Cancer Institute; HistoGenetics, Inc.; Incyte Corporation; Jeff Gordon Children's Foundation; Kiadis Pharma; The Leukemia & Lymphoma Society; Medac GmbH; The Medical College of Wisconsin; Merck & Co, Inc.; Millennium: The Takeda Oncology Co.; Milliman USA, Onyx Pharmaceuticals; Optum Healthcare Solutions, Inc.; Osiris Therapeutics, Inc.; Otsuka America Pharmaceutical, Inc.; Perkin Elmer, Inc.; Remedy Informatics; Sanofi US; Seattle Genetics; Sigma-Tau Pharmaceuticals; Soligenix, Inc.; St. Baldrick's Foundation; StemCyte, A Global Cord Blood Therapeutics Co.; Stemsoft Software, Inc.; Swedish Orphan Biovitrum; Tarix Pharmaceuticals; TerumoBCT; Teva Neuroscience, Inc.; THERAKOS, Inc.; University of Minnesota; University of Utah; and Wellpoint, Inc. The views expressed in this article do not reflect the official policy or position of the National Institute of Health, the Department of the Navy, the Department of Defense, Health Resources and Services Administration (HRSA) or any other agency of the U.S. Government.-
dc.language.isoen-
dc.publisherWILEY-BLACKWELL-
dc.rights© 2014 John Wiley & Sons Ltd.-
dc.titleThe influence of interleukin-7 receptor alpha-chain haplotypes on outcome after allogeneic hematopoietic cell transplantation-
dc.typeJournal Contribution-
dc.identifier.epage527-
dc.identifier.issue6-
dc.identifier.spage521-
dc.identifier.volume41-
local.format.pages7-
local.bibliographicCitation.jcatA1-
dc.description.notes[Broux, B.; Stinissen, P.; Hellings, N.] Hasselt Univ, Biomed Res Inst, Sch Life Sci, B-3590 Diepenbeek, Belgium. [Broux, B.; Stinissen, P.; Hellings, N.] Transnationale Univ Limburg, Diepenbeek, Belgium. [Shamim, Z.; Ryder, L. P.] Univ Hosp Rigshosp, Dept Clin Immunol Sect 7631, Copenhagen, Denmark. [Shamim, Z.; Muller, K.] Univ Hosp Rigshosp, Inst Inflammat Res Sect 7541, Copenhagen, Denmark. [Wang, T.] Med Coll Wisconsin, Div Biostat, Milwaukee, WI 53226 USA. [Spellman, S.; Haagenson, M.] CIBMTR, Dept Immunobiol & Observat Res, Minneapolis, MN USA. [Muller, K.] Univ Hosp Rigshosp, Dept Pediat & Adolescent Med 4072, Copenhagen, Denmark.-
local.publisher.placeHOBOKEN-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1111/iji.12158-
dc.identifier.isi000345297600013-
item.fullcitationBROUX, Bieke; Shamim, Z.; Wang, T.; Spellman, S.; Haagenson, M.; STINISSEN, Piet; Ryder, L. P.; Muller, K. & HELLINGS, Niels (2014) The influence of interleukin-7 receptor alpha-chain haplotypes on outcome after allogeneic hematopoietic cell transplantation. In: INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 41 (6), p. 521-527.-
item.contributorBROUX, Bieke-
item.contributorShamim, Z.-
item.contributorWang, T.-
item.contributorSpellman, S.-
item.contributorHaagenson, M.-
item.contributorSTINISSEN, Piet-
item.contributorRyder, L. P.-
item.contributorMuller, K.-
item.contributorHELLINGS, Niels-
item.validationecoom 2015-
item.fulltextWith Fulltext-
item.accessRightsRestricted Access-
crisitem.journal.issn1744-3121-
crisitem.journal.eissn1744-313X-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
iji12158.pdf
  Restricted Access		87.14 kBAdobe PDFView/Open    Request a copy
Show simple item record

SCOPUSTM   
Citations

2
checked on Sep 3, 2020

WEB OF SCIENCETM
Citations

2
checked on Apr 14, 2024

Page view(s)

34
checked on Aug 31, 2022

Download(s)

14
checked on Aug 31, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.